×
For best experience we recommend to activate Javascript in your browser.
CDON antibody (AA 1095-1211) (FITC)
The FITC-conjugated Rabbit Polyclonal anti-CDON antibody (ABIN6108946) specifically detects CDON in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN6108946
$580.46
Plus shipping costs $50.00
20 μL ABIN6108945
50 μL ABIN5898405
100 μL ABIN6108946
20 μL ABIN6108945
50 μL ABIN5898405
100 μL ABIN6108946
Delivery in 10 to 18 Business Days
Quick Overview for CDON antibody (AA 1095-1211) (FITC) (ABIN6108946)
Target
See all CDON Antibodies
CDON
(Cell Adhesion Molecule-Related/down-Regulated By Oncogenes (CDON))
Reactivity
All reactivities for CDON antibodies
Human
Host
All hosts for CDON antibodies
Rabbit
Clonality
All clonalities for CDON antibodies
Polyclonal
Conjugate
All conjugates for CDON antibodies
This CDON antibody is conjugated to FITC
Application
All applications for CDON antibodies
ELISA
Product Details anti-CDON Antibody (FITC)
(hide)
Binding Specificity
All epitopes for CDON antibodies
AA 1095-1211
Purification
Protein G
Immunogen
Recombinant Human Cell adhesion molecule-related/down-regulated by oncogenes protein (1095-1211AA).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03 % Proclin-300 and 50 % Glycerol.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C,-80 °C
Storage Comment
Aliquot and store at -20 °C or -80 °C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Target Details for CDON
(hide)
Target
CDON
(Cell Adhesion Molecule-Related/down-Regulated By Oncogenes (CDON))
Alternative Name
CDON
Gene ID
50937
UniProt
Q4KMG0
Pathways
Regulation of Muscle Cell Differentiation , Skeletal Muscle Fiber Development , Embryonic Body Morphogenesis
Recently viewed
(hide)
Chat with us , powered by LiveChat